The American Society of Anesthesiologists (ASA) today announced the launch of two new monthly podcasts for physician anesthesiologists, the anesthesia care team, residents, medical students and anesthesiology community.
Granulocyte colony-stimulating factor (GCSF) is currently used to treat neutropenia due to chemotherapy and has been successfully used for patients who require bone marrow transplants. The study is the first to report on the neuroprotective effect of GCSF in vivo and showed that it improved neurological deficits that occur in the first few days following cerebral ischemia. GCSF improved long-term behavioral outcomes while also stimulating a neural progenitor recovery response in a mouse model.
Research by a University of Georgia psychologist shows that targeting one particular symptom of schizophrenia has a positive effect on other symptoms.
The American Society of Anesthesiologists (ASA) and the South Dakota Society of Anesthesiologists (SDSA) strongly oppose SB 50, which will needlessly dismantle the anesthesia care team model in South Dakota by authorizing nurse anesthetists to administer anesthesia without physician supervision. Additionally, the bill will authorize nurse anesthetists to prescribe patients potentially dangerous controlled substances, including opioids, and perform intricate pain medicine procedures all with no physician oversight or involvement.
Promising intracellular protein-based therapeutics have been of limited use due to the difficulty of delivery into diseased cells. Now bioengineers have developed nanoparticles that can deliver these therapeutics to their targets—avoiding degradation and toxic interactions with healthy tissues.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that orthostatic hypotension was not associated with higher risk of cardiovascular events, falls, or fainting among participants in The Systolic Blood Pressure Intervention Trial. In a study published in the journal Hypertension, the scientists showed that hypertension treatment had no impact on the link between OH and cardiovascular outcomes or other adverse events.
A new study led by physician-researchers at Beth Israel Deaconess Medical Center (BIDMC) reports that the antihypertensive drug amlodipine lowered long-term gout risk compared to two other drugs commonly prescribed to lower blood pressure. The findings are published in the Journal of Hypertension.
A new drug that could make it easier for doctors to diagnose multiple sclerosis (MS) in its earlier stages has been approved for its first human trials by the U.S. Food and Drug Administration (FDA).
Individuals with a history of early life adversity (ELA) are disproportionately prone to opioid addiction. A new UCI-led study reveals why. Published in Molecular Psychiatry, the study titled, “On the early life origins of vulnerability to opioid addiction,” examines how early adversities interact with factors such as increased access to opioids to directly influence brain development and function, causing a higher potential for opioid addiction.
Approximately one-quarter of patients who are prescribed opioids for chronic pain misuse them, with five to 10 percent developing an opioid use disorder or addiction. In a new study, UC San Diego researchers found that opioid dependence produced permanent changes in the brains of rats.
As we enter a new year and a new decade, many states have enacted legislation affecting the roles of advanced practice registered nurses (APRNs) in terms of practice authority, reimbursement, and prescriptive authority, according to the 32nd Annual Legislative Update in the January issue of The Nurse Practitioner, published by Wolters Kluwer.
Many Medicare patients with new episodes of low back pain receive care inconsistent with current guidelines – including high use of opioids and advanced imaging tests, reports a study in the February issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.
Surgeons at Houston Methodist Hospital are stemming the tide of addiction to prescription opioids by managing patients’ pain after surgery. By using long-acting local anesthetics at the site of surgery and scheduled non-narcotic pain medicine, they decreased opioid prescriptions from 87% to 10% after surgery.
Complimentary press passes and virtual newsroom access are now available for the Experimental Biology (EB) 2020 meeting, to be held April 4–7 in San Diego.
A study of more than 4 million Medicaid claims records during a recent seven-year period concludes that less than a third of the nearly 3,800 U.S. adolescents and young adults who experienced a nonfatal opioid overdose got timely (within 30 days) follow-up addiction treatment to curb or prevent future misuse and reduce the risk of a second overdose.
The goal of the survey is to collect data that will help experts develop interventions to support musicians.
A series of seven articles in AACN Advanced Critical Care focuses on the challenges of safe, effective pain management in the ICU, including more Americans reporting daily chronic pain and the rapidly increasing prevalence of opioid misuse and opioid use disorder.
The expansion of Medicaid coverage for low-income adults permitted by the Affordable Care Act (ACA) was associated with a six percent reduction in total opioid overdose deaths nationally, according to new research from NYU Grossman School of Medicine and University of California, Davis.
With $3 million in funding from NIDA and NIGMS, UK College of Arts & Sciences Professor Carrie Oser is leading a new study focusing on factors that influence a person’s decision to use one of the three FDA-approved medications for the treatment of opioid use disorder in the criminal justice setting.
Low-income people with addiction, especially those with addiction to opioids, may find it hard to access the kind of care they need to recover no matter where they live, a new study suggests. But treatment for opioid problems is especially scarce in states that may drop people from their Medicaid health insurance rolls -- unless they can show that they’re working, in school, have a disability or are medically frail or receiving treatment for substance use disorder.
New research into the biology of depression, along with new and evolving technologies, provides the basis for developing the next generation of treatments for major depressive disorder (MDD), according to the special January/February issue of Harvard Review of Psychiatry. The journal is published in the Lippincott portfolio by Wolters Kluwer.
At a family medicine clinic in the Boston area, a team led by faculty from Tufts University School of Medicine conducted a five-year case study where they found medical facilities can help physicians to treat chronic pain in a way that will deter opioid misuse, while creating better processes to identify and treat patients who develop an opioid use disorder.
Only a tiny minority of people at risk for an opioid overdose actually are prescribed a drug that could save their lives, a new study suggests. And the odds of having a dose of the rescue drug were very low among some of the most at-risk groups, including those who had already survived a previous opioid overdose.
Of three possible ways for people to deliver the life-saving antidote naloxone to a person experiencing an opioid overdose, the use of a nasal spray was the quickest and easiest according to research conducted by William Eggleston, clinical assistant professor at Binghamton University, State University of New York, and colleagues at SUNY Upstate Medical University.
A risk-management program set up in 2012 by the U.S. Food and Drug Administration to curb improper prescribing of extended-release and long-acting opioids may not have been effective because of shortcomings in the program’s design and execution, according to a paper from researchers at the Johns Hopkins Bloomberg School of Public Health.
Closing of local automotive assembly plants may lead to increases in deaths from opioid overdose, according to a study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and the Massachusetts General Hospital. The findings highlight fading economic opportunity as a driving factor in the ongoing national opioid epidemic, and build on previous research that links declining participation in the labor force to increased opioid use in the U.S. The findings are published today in JAMA Internal Medicine.
Leftover prescription opioids pose big risks to kids, yet most parents keep their own and their child's unused painkillers even after they're no longer medically necessary for pain.
Despite a national opioid crisis, prescribed opioid analgesics remain a viable option for pain management for patients with cancer. In effect, patients with cancer represent one of the few groups excluded from most state legislation and policy initiatives on prescribing opioids as well as from opioid stewardship programs of many health systems. However, little is understood about oncology patients’ opioid self-management practices and potential safety risk that may stem from these practices.
The number of teens taking and overdosing from benzodiazepines, commonly prescribed anxiety medications, has risen dramatically over the past decade, according to a national study coauthored by Rutgers researchers.
Older teens may have similar risk factors for prescription opioid overdose as adults, a new study suggests.
DHS S&T, the White House ONDCP, U.S. CBP, and the USPIS announced the grand prize winner and runner-up in the Opioid Detection Challenge, a $1.55 million global prize competition for rapid, nonintrusive detection tools that will help find illicit opioids in international mail.
FAU and GSU have partnered on a program to assist children and families affected by addiction. They have received a $2.64 million grant from the U.S. Department of Health and Human Services for a program aimed at improving outcomes of Georgia’s children and families and strengthening the partnership between the Division of Family and Children Services and family treatment courts.
Two researchers from Penn State College of Medicine have received nearly $5 million from the National Institutes of Health to study whether an already-approved drug can be used to reduce cravings and prevent relapse in those struggling with opioid addiction.
A recently published study shows the United States in the grip of several simultaneously occurring opioid epidemics, rather than just a single crisis. The epidemics came to light after the researchers analyzed county-level data on drug overdose deaths. The study highlights the importance of different policy responses to the epidemics rather than a single set of policies.
People in treatment for opioid addiction are more likely to relapse when they become more tolerant of risks, according to a study by Rutgers and other institutions. The findings can help clinicians better predict which patients are most vulnerable.
A computer betting game can help predict the likelihood that someone recovering from opioid addiction will reuse the pain-relieving drugs, a new study shows.
A study published in the Journal of Substance Abuse Treatment of 799 patients in three locations found that methamphetamine use was associated with more than twice the risk for dropping out of treatment for opioid-use disorder.
People who abuse cigarettes, alcohol and/or heroin are less likely to drop out of a substance use disorder treatment than those who are addicted to cocaine, according to a new study led by a researcher at the University of Alabama at Birmingham. The study found that approximately 30 percent of participants in psychosocial substance use disorder treatments do not finish the programs. This is the first time a study of this kind has been published.
Preventing chronic disease could help curb the opioid epidemic, according to research from the University of Georgia. The study is the first to examine the relationship between hospitalizations due to opioid misuse and chronic disease.
DARPA-funded project called STOP PAIN aimed at the design of safer, more effective pain treatments Research to focus on understanding the biology of pain as a way to transform clinical care, help stem the public health crisis fueled by opioids Efforts will encompass expertise from fields including neurobiology, stem cell biology, artificial intelligence and computational and medicinal chemistry
A study published in Neuropsychopharmacology reported that addiction relapse can be prevented by controlling cells in a brain region called the nucleus accumbens.
DHS S&T in partnership with the U.S. Customs and Border Protection, the White House ONDCP, and USPIS will announce the winning technologies in the Opioid Detection Challenge at 11:00 a.m., Thursday, December 12, 2019 at the DHS TSL in Egg Harbor Township, NJ.
The University of Illinois at Chicago has received a grant from the Coleman Foundation to develop a screening process for prescribing opioids and managing opioid use disorders in cancer patients who receive care at UI Health, UIC’s clinical health enterprise.
Inhaled cannabis reduces self-reported headache severity by 47.3% and migraine severity by 49.6%, according to a recent study led by Carrie Cuttler, a Washington State University assistant professor of psychology.
Fentanyl overdoses cluster geographically more than non-fentanyl overdoses, according to a study just released by Columbia University Mailman School of Public Health.
With no national standard to measure drug treatment facilities, new research reveals opportunities to learn from patients to help create metrics.
Researchers have discovered that a peptide links together migraine pain and pain induced by opioid overuse.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right